Login / Signup
Floris Dammeijer
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Stem Cell Transplantation
Mouse Model
High Dose
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Floris Dammeijer
,
Mandy van Gulijk
,
Larissa Klaase
,
Menno van Nimwegen
,
Rachid Bouzid
,
Robin Hoogenboom
,
Maria E Joosse
,
Rudi W Hendriks
,
Thorbald van Hall
,
Joachim G J V Aerts
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.
Molecular cancer therapeutics
21 (9) (2022)